Cargando…
P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma
SIMPLE SUMMARY: Clinical experience in human and canine clinics shows that following initial response to treatment, drug-resistant cancer cells frequently evolve and eventually, most tumors become resistant to all available therapies. The most straightforward cause of therapy resistance is linked to...
Autores principales: | Dékay, Valéria, Karai, Edina, Füredi, András, Szebényi, Kornélia, Szakács, Gergely, Vajdovich, Péter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405845/ https://www.ncbi.nlm.nih.gov/pubmed/36010910 http://dx.doi.org/10.3390/cancers14163919 |
Ejemplares similares
-
Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
por: Karai, Edina, et al.
Publicado: (2020) -
Generation of a Homozygous Transgenic Rat Strain Stably Expressing a Calcium Sensor Protein for Direct Examination of Calcium Signaling
por: Szebényi, Kornélia, et al.
Publicado: (2015) -
Establishment and Characterization of a Brca1(−/−), p53(−/−) Mouse Mammary Tumor Cell Line
por: Hámori, Lilla, et al.
Publicado: (2020) -
Comparison of Different Clinical Chemotherapeutical Agents’ Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells
por: Vajda, Flóra, et al.
Publicado: (2022) -
Extensive astrocyte synchronization advances neuronal coupling in slow wave activity in vivo
por: Szabó, Zsolt, et al.
Publicado: (2017)